In the Grassley-Wyden 2-year investigation into insulin price-gouging, we found that that PBM scheme encourages drug makers to spike the drug list price.

The Prescription Pricing for the People bill requires the FTC to study pharmaceutical intermediaries, including vertical integration.

I believe it is our duty to understand how the pharmaceutical supply chain is working, and what we can do to improve it.

States know who the recipients are because they administer the SNAP Program, and they also know where the jobs are.

I think it is important for people to know who is actually receiving SNAP.

States know who the recipients are because they administer the SNAP Program, and they also know where the jobs are.

There is not enough money in that program.

I think it is important for people to know who is actually receiving SNAP.

The current drug price system is so opaque that it is easy to see why there are many questions about PBM motives and practices.

In the Grassley-Wyden 2-year investigation into insulin price-gouging, we found that that PBM scheme encourages drug makers to spike the drug list price.

Prohibits deceptive, unfair pricing schemes, including spread pricing and arbitrary clawbacks of payments made to pharmacies.

This bill puts sunshine on PBMs and saves taxpayers $740 million.

There is not enough money in that program.

The Pharmacy Benefit Manager (PBM) Transparency Act (S. 127) requires transparency reporting by PBMs to shine sunlight on prices and fees associated with prescription drugs.

I urge all the members of this committee to support this important legislation.

I think that sometimes when there is a will, there is a way and perhaps we need to give the VA the will to make the way happen.

It would mean 84,000 farmers couldn't access the technical assistance they need to embrace conservation practices.

I mean our heart goes out. As a former governor, I have toured many tornado damaged sites, and it is absolutely devastating to people.